Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature

Lacro, Jonathan P., Dunn, Laura B., Dolder, Christian R., Leckband, Susan G., Jeste, Dilip V.·2002·The Journal of Clinical Psychiatry

DOI 10.4088/jcp.v63n1007

Cited by (1,000)

Items 401–500 of 1,000

Attitude towards adherence in patients with schizophrenia at discharge
Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, Michael Obermeier, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel et al. · 2009 · Journal of Psychiatric Research
Subjectivity and Schizophrenia: Another Look at Incomprehensibility and Treatment Nonadherence
Josef Parnas, Mads Gram Henriksen · 2013 · Psychopathology
Educational interventions for mental health consumers receiving psychotropic medication: A review of the evidence
Ritin Santiago Fernandez, Venita Evans, Rhonda D Griffiths, Maria S Mostacchi · 2006 · International Journal of Mental Health Nursing
Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): A six-month follow-up study
Susanne Jaeger, Carmen Pfiffner, Prisca Weiser, Reinhold Kilian, Thomas M Becker, Gerhard Längle, Gerhard Wilhelm Eschweiler, Daniela Croissant, Wiltrud Schepp, Tilman Steinert · 2012 · Psychiatry Research
Mental Health Curricula at Schools of Pharmacy in the United Kingdom and Recent Graduates’ Readiness to Practice
Paul M Rutter, Denise Taylor, Dave Branford · 2013 · American Journal of Pharmaceutical Education
Cultural Beliefs Underlying Medication Adherence in People of Chinese Descent in the United States
Lan Jin, Lalatendu Acharya · 2015 · Health Communication
A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
Alex J. Kopelowicz, Ross A. Baker, Cathy Yunjia Zhao, Claudette Brewer, Erica Lawson, Timothy S. Peters-Strickland · 2017 · Neuropsychiatric Disease and Treatment
Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individuals
Rebecca Harrison, Fiona Gaughran, Robin M. Murray, Sang Hyuck Lee, Jose Luis Paya-Cano, David Dempster, Charles J. C. Curtis, Danai Dima, Hamel Patel, Simone de Jong et al. · 2017 · Scientific Reports
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials
Wang, Dongfang, Schneider-Thoma, Johannes, Siafis, Spyridon, Burschinski, Angelika, Dong, Shimeng, Wu, Hui, Zhu, Yikang, Davis, John M, Priller, Josef, Leucht, Stefan · 2024 · Schizophrenia Bulletin
Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting
Kruti Joshi, Marie‐Hélène Lafeuille, Brianne Brown, Willy Wynant, Bruno Émond, Patrick Lefèbvre, Neeta Tandon · 2017 · Current Medical Research and Opinion
Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis
Townsend M, Kristin Pareja, Amy Buchanan-Hughes, Emma Worthington, David Pritchett, Malaak Brubaker, Christy R. Houle, Tenna Natascha Mose, Heidi C. Waters · 2022 · DOAJ (DOAJ: Directory of Open Access Journals)
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points
Francesco Pisani, Laura Rosa Pisani, María Antonietta Barbieri, José de León, Edoardo Spina · 2022 · Current Neuropharmacology
Antipsychotic medication, mortality and neurodegeneration: The need for more selective use and lower doses
Stefan Weinmann, Volkmar Aderhold · 2009 · Psychosis
Polypharmacy with antipsychotic drugs in patients with schizophrenia: Trends in multiple health care systems
Fangfang Sun, Eileen M. Stock, Laurel Anne Copeland, John E. Zeber, Brian Kenneth Ahmedani, Sandra Baker Morissette · 2014 · American Journal of Health-System Pharmacy
The impact of non-adherence to medication in patients with schizophrenia on health, social care and societal costs. Analysis of the QUATRO study
Derek King, Martin Richard John Knapp, Anita K. Patel, Francesco Amaddeo, Michele Tansella, Aart H. Schene, Maarten W.J. Koeter, Matthias C. Angermeyer, Thomas M Becker · 2013 · Epidemiology and Psychiatric Sciences
Relationship between adherence, symptoms, treatment attitudes, satisfaction, and side effects in prisoners taking antipsychotic medication
Richard John Gray, Daniel Thomas Bressington, Judith Lathlean, Alice Mills · 2008 · Journal of Forensic Psychiatry and Psychology
Adherence to Antipsychotic Medication by Community-Based Patients With Schizophrenia in China: A Cross-Sectional Study
Xun Wang, Wufang Zhang, Ning Ma, Lili Guan, Samuel Law, Xin Yu, Hong Ma · 2016 · Psychiatric Services
The impact of negative treatment experiences on persistent refusal of antipsychotics
Tania M. Lincoln, Esther Jung, Martin Wiesjahn, Hanna Wendt, Thomas A. Bock, Björn Schlier · 2016 · Comprehensive Psychiatry
Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial
Stefan Priebe, Stephen A. Bremner, Christoph Lauber, Catherine Henderson, Tom Burns · 2016 · Health Technology Assessment
Religious Beliefs and Their Relevance for Treatment Adherence in Mental Illness: A Review
Paweł Zagożdżon, Magdalena Wrotkowska · 2017 · Religions
Efficacy of Cognitive Nursing Intervention for Voice Hearing
Margaret England · 2007 · Perspectives In Psychiatric Care
The impact of subjective well-being under neuroleptic treatment on compliance and remission
Walter de Millas, Martin Lambert, Dieter Naber · 2006 · Dialogues in Clinical Neuroscience
Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial
Ayeesha Kamran Kamal, Quratulain Shaikh, Omrana Pasha, Iqbal Azam, Muhammad Shahidul Islam, Adeel Memon, Hasan Rehman, Muhammad Affan, Sumaira Nazir, Salman Aziz et al. · 2015 · BMC Neurology
Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study
Stefanie N. Rezansoff, Akm Moniruzzaman, Seena Fazel, Ric M. Procyshyn, Julian M. Somers · 2016 · Social Psychiatry and Psychiatric Epidemiology
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
Norio Sugawara, Shuhei Kudo, Masamichi Ishioka, Yasushi Sato, Kazutoshi Kubo, Norio Yasui‐Furukori · 2019 · Neuropsychiatric Disease and Treatment
Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study
Maria Fagerbakke Strømme, Liv Mellesdal, Christoffer Andreas Bartz-Johannessen, Rune A. Kroken, Marianne L. Krogenes, Lars Ivar Mehlum, Erik Johnsen · 2021 · Schizophrenia Research
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
Giulia Maria Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci, Silvana Galderisi · 2022 · Frontiers in Psychiatry
Medication Nonadherence and Risk of Violence to Others Among Patients With Schizophrenia in Western China
Yang Li, Hong Wen, Chaoxinyu Xiong, Chunying Lin, Xianmei Yang, Dan Wang, Ruoxing Fan, Jun Liu, Xing Zhao, Yuanyuan Liu et al. · 2023 · JAMA Network Open
Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia
Stefan Westermann, Marialuisa Cavelti, Eva Heibach, Franz Caspar · 2015 · Frontiers in Psychology
An exploration of the therapeutic alliance within a telephone‐based cognitive behaviour therapy for individuals with experience of psychosis
John Mulligan, Gillian Haddock, Samantha Hartley, Josie Davies, Tom Sharp, JAMES A. KELLY, Sandra T. Neil, Christopher D. J. Taylor, Mary Welford, Jason Price et al. · 2014 · Psychology and Psychotherapy Theory Research and Practice
Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
Radovan Přikryl, Hana Přikrylová Kučerová, Michaela Vrzalová, Eva Češková · 2012 · Schizophrenia Research and Treatment
Evaluation of a Discharge Medication Service on an Acute Psychiatric Unit
John R. Tomko, Nadeem Ahmed, Koushik Mukherjee, Rebecca S. Roma, Donna DiLucente, Karen Orchowski · 2013 · Hospital Pharmacy
Case Manager- and Patient-Rated Alliance as a Predictor of Medication Adherence in First-Episode Psychosis
Tina C. Montreuil, Clifford Cassidy, Mark Rabinovitch, Nicole Pawliuk, Norbert Schmitz, Ridha Joober, ASHOK K. MALLA · 2012 · Journal of Clinical Psychopharmacology
Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia
José Manuel Olivares, Beatriz Pinal, Carmen Cinos · 2011 · Neuropsychiatry
Mobile phone text message reminders of antipsychotic medication: is it time and who should receive them? A cross-sectional trust-wide survey of psychiatric inpatients
Katherine Bogart, Sook Kuan Wong, Christine Lewis, Anthony Akenzua, Daniel Hayes, Athanasios Prountzos, Chike Ify Okocha, Eugenia Kravariti · 2014 · BMC Psychiatry
Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics
Rimal B. Bera, Steve J. Offord, Donna Zubek, Gina Lau, Jay Lin, Ross A. Baker, Craig N. Karson · 2013 · Journal of Medical Economics
Pharmacogenetic study of atypical antipsychotic drug response: Involvement of the norepinephrine transporter gene
A. Méary, Georges Brousse, Stéphane Jamain, A. Schmitt, Andreı̈ Szöke, Franck Schürhoff, Gilles Gavaudan, Christophe Lançon, I. Macquin‐Mavier, Marion Leboyer et al. · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience
K. Zemmour, Aurélie Tinland, Mohamed Boucékine, Vincent Girard, Sandrine Loubière, Noémie Resseguier, Guillaume B. Fond, Pascal Auquier, Laurent Boyer, French Housing First Study Group et al. · 2016 · Scientific Reports
Dimensions of insight in schizophrenia: Exploratory factor analysis of items from multiple self- and interviewer-rated measures of insight
Susanna Konsztowicz, Norbert Schmitz, Martín Lepage · 2018 · Schizophrenia Research
Transcranial Direct Current Stimulation, Symptomatology, and Cognition in Psychosis: A Qualitative Review
Tina Gupta, Nicholas J. Kelley, Andrea Pelletier‐Baldelli, Vijay Anand Mittal · 2018 · Frontiers in Behavioral Neuroscience
Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure
Kanae Su, Takao Kato, Mamoru Toyofuku, Takeshi Morimoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa et al. · 2019 · Circulation Reports
Shelter-based Convalescence for Homeless Adults
Tiina Podymow, Jeff Turnbull, Vela Tadic, Wendy Muckle · 2006 · Canadian Journal of Public Health
Understanding and Improving Treatment Adherence in Patients with Psychotic Disorders: A Review and a Proposed Intervention
Anton B. P. Staring, Cornelis L. Mulder, Mark van der Gaag, Jean‐Paul Selten, ANTON J. M. LOONEN, Michiel W. Hengeveld · 2006 · Current Psychiatry Reviews
Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial
Huan-Hwa Chen, Hsin‐Tien Hsu, Pei‐Chao Lin, Chin‐Yin Chen, Hsiu‐Fen Hsieh, Chih‐Hung Ko · 2023 · JMIR Mental Health
Adherence to Treatment and Therapeutic Strategies in Schizophrenic Patients: The ADHERE Study
José Ramón Gutiérrez-Casares, Fernando Cañas, David Alonso‐Escolano, Rebeca Hidalgo Borrajo, Alexander Rodríguez-Morales · 2010 · CNS Spectrums
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
Yongling Xiao, Erik Muser, Marie‐Hélène Lafeuille, Jacqueline A. Pesa, John M. Fastenau, Mei Sheng Duh, Patrick Lefèbvre · 2015 · Journal of Comparative Effectiveness Research
La adherencia predice la remisión sintomática y psicosocial en esquizofrenia: estudio naturalístico de la integración de los pacientes en la comunidad
Miquel Bernardo, Fernando Cañas, Berta Herrera, Marta García Dorado · 2016 · Revista de Psiquiatría y Salud Mental
Perception of Community Pharmacists in Malaysia About Mental Healthcare and Barriers to Providing Pharmaceutical Care Services to Patients with Mental Disorders
Yin Xuan Wong, Tahir Mehmood Khan, Zhi Jean Wong, Ab Fatah Ab Rahman, Sabrina Anne Jacob · 2019 · Community Mental Health Journal
The paradoxical role of insight in mental illness: The experience of stigma and shame in schizophrenia, mood disorders, and anxiety disorders
Tzipi Buchman-Wildbaum, Enikő Váradi, Ágoston Schmelowszky, Mark Damian Griffiths, Zsolt Demetrovics, Róbert Urbán · 2020 · Archives of Psychiatric Nursing
The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review
Jobbe Goossens, Manuel Morrens, Violette Coppens · 2021 · Molecular Diagnosis & Therapy
Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets
A. Grace, D. Uliana · 2023 · International Journal of Molecular Sciences
Routine Outcomes Monitoring to Support Improving Care for Schizophrenia: Report from the VA Mental Health QUERI
Alexander S. Young, Noosha Niv, Matthew Chinman, Lisa B. Dixon, Susan V. Eisen, Ellen P. Fischer, Jeffrey L. Smith, Marcia M. Valenstein, Stephen R. Marder, Richard R. Owen · 2010 · Community Mental Health Journal
Validation of the Illness Perception Questionnaire for Schizophrenia in a German-Speaking Sample of Outpatients with Chronic Schizophrenia
Marialuisa Cavelti, Giuliana Contin, Eva‐Marina Beck, Sara Kvrgic, Joe Kossowsky, Rolf‐Dieter Stieglitz, Roland Vauth · 2012 · Psychopathology
Medication Adherence, Knowledge About Psychosis, and Insight Among Patients With a Schizophrenia-Spectrum Disorder
Sherry Kit Wa Chan, Christy Lai Ming Hui, Gloria Hoi Yan Wong, Edwin Ho Ming Lee, Wing Chung Chang, Eric Yu Hai Chen · 2013 · The Journal of Nervous and Mental Disease
Comparative Effectiveness of Second-Generation Antipsychotic Medications in Early-Onset Schizophrenia
Mark Olfson, Tobias Gerhard, Chun Yang Huang, J LIEBERMAN, William Victor Bobo, Stephen Crystal · 2011 · Schizophrenia Bulletin
The Amsterdam Studies of Acute Psychiatry I (ASAP-I); A prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan area
Louk van der Post, Robert A. Schoevers, Vincent Koppelmans, Irene Visch, Clemens M. L. Bernardt, Niels L. Mulder, Aartjan T.F. Beekman, Lieuwe de Haan, Jack Dekker · 2008 · BMC Psychiatry
Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta analysis
Michelle Angela Richardson, Rose McCabe, Stefan Priebe · 2012 · Social Psychiatry and Psychiatric Epidemiology
Insights into hallucinations in schizophrenia: Novel treatment approaches
Aleman, André, Larøi, Frank · 2011 · Expert Review of Neurotherapeutics
Barriers to medication adherence for rural patients with mental disorders in eastern China: a qualitative study
Xiaoyun Chai, Ying Liu, Zhuxin Mao, Shunping Li · 2021 · BMC Psychiatry
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
Merhawi Bahta, Azieb Ogbaghebriel, Mulugeta Russom, Eyasu Habte Tesfamariam, Tzeggai Berhe · 2021 · Annals of General Psychiatry
The experiences of 585 people when they tried to withdraw from antipsychotic drugs
John Read · 2022 · Addictive Behaviors Reports
Factors related to missed first appointments after discharge among patients with schizophrenia in Taiwan
Kai-Da Cheng, Chun‐Jen Huang, Hin‐Yeung Tsang, Ching‐Hua Lin · 2012 · Journal of the Formosan Medical Association
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia
Sandra L. Tunis, Douglas E. Faries, Michael D. Stensland, Donald P. Hay, Bruce J. Kinon · 2006 · Current Medical Research and Opinion
Attitudes toward taking medication among outpatients with schizophrenia: cross-national comparison between Tokyo and Beijing
Naoaki Kuroda, Shiyou Sun, Chih‐Kuang Lin, Nobuaki Morita, Hirotaka Kashiwase, Fude Yang, Yoji Nakatani · 2008 · Environmental Health and Preventive Medicine
A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: A one-year mirror-image study with national claim-based database in Taiwan
Hui-Chih Chang, Chao‐Hsiun Tang, Sheng-Tzu Huang, Paul McCrone, Kuan‐Pin Su · 2012 · Journal of Psychiatric Research
Measurement of Insight in Patients With Bipolar Disorder
Halldóra Jónsdóttir, John Abel Engh, Svein Friis, Astrid B. Birkenaes, Petter Andreas Ringen, Anja Vaskinn, Kjetil S. Sundet, Stein Opjordsmoen, Ole A. Andreassen · 2008 · The Journal of Nervous and Mental Disease
An empirical evaluation of recovery transformation at a large community psychiatric rehabilitation organization.
Igor Malinovsky, Paul M. Lehrer, Steven M. Silverstein, Stewart A. Shankman, William Hayes O’Brien, Tracy Samuelson, Gary van Nostrand · 2013 · Psychological Services
Prescribing in Prison
Patricia D. Pilkinton, James C. Pilkinton · 2014 · Journal of Correctional Health Care
Factors contributing the outcome of Schizophrenia in developing and developed countries: A brief review
Mahmuda Naheed, Khondoker Ayesha Akter, Fatema Tabassum, Rumana Mawla, Mahmudur Rahman · 1970 · International Current Pharmaceutical Journal
Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period
Profit, Deborah, Rohatagi, Shashank, Zhao, Cathy, Hatch, Ainslie, Docherty, John P., Peters-Strickland, Timothy S. · 2016 · The Journal of Clinical Psychiatry
Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence
Anthony P. Morrison · 2018 · Schizophrenia Research
A narrative review of studies of refusal of psychotropic medication in acute inpatient psychiatric care
John Arianda Owiti, Len Bowers · 2011 · Journal of Psychiatric and Mental Health Nursing
Time to Discontinuation and Self-Discontinuation of Olanzapine and Risperidone in Patients With Schizophrenia in a Naturalistic Outpatient Setting
Nael Kilzieh, Jeffrey A. Todd–Stenberg, Annette Kennedy, Amanda Ernst Wood, Andre M. Tapp · 2008 · Journal of Clinical Psychopharmacology
Does Level of Care, Sex, Age, or Choice of Drug Influence Adherence to Treatment With Antipsychotics?
Ingrid Castberg, Andreas Austgulen Westin, Olav Spigset · 2009 · Journal of Clinical Psychopharmacology
Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, Kensuke Nomura, Akira Tanabe, Koichiro Watanabe, Gohei Yagi, Haruo Kashima · 2005 · Psychopharmacology
The medical care of people with psychosis
Timothy Lambert · 2009 · The Medical Journal of Australia
Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge
Zhou, Yanling, Rosenheck, Robert, Mohamed, Somaia, Ning, Yuping, He, Hongbo · 2017 · Psychiatry Research
Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER
Zafar A. Sharif · 2008 · Patient Preference and Adherence
Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.
Marie‐Hélène Lafeuille, Christian Frois, Michel Cloutier, Mei Sheng Duh, Patrick Lefèbvre, Jacqueline A. Pesa, Zoe Clancy, John M. Fastenau, Mike Durkin · 2016 · Europe PMC (PubMed Central)
Population Pharmacokinetic Modeling and Exposure‐Response Analysis for Aripiprazole Once Monthly in Subjects With Schizophrenia
Xiaofeng Wang, Arash Raoufinia, Sébastien Bihorel, Julie A. Passarell, Suresh Mallikaarjun, Luann Phillips · 2022 · Clinical Pharmacology in Drug Development
A review of Motivational Interviewing to enhance adherence to antipsychotic medication in patients with schizophrenia: Evidence and recommendations
Walter Matthew Drymalski, Todd C. Campbell · 2008 · Journal of Mental Health
The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series
Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Kim · 2009 · Journal of Psychopharmacology
Treatment Engagement of Psychotic Patients with a Mobile Mental Health Unit in Rural Areas in Greece: A Five-Year Study
Vaios Peritogiannis, Athina Tatsioni, Nefeli Menti, Aikaterini Grammeniati, Vassiliki Fotopoulou, Venetsanos G. Mavreas · 2013 · Schizophrenia Research and Treatment
Explaining Attitudes and Adherence to Antipsychotic Medication: The Development of a Process Model
Martin Wiesjahn, Esther Jung, Fabian Lamster, Winfried Rief, Tania M. Lincoln · 2014 · Schizophrenia Research and Treatment
Pharmacotherapy of patients with schizophrenia and substance abuse
Thomas Wobrock, Michael Soyka · 2009 · Expert Opinion on Pharmacotherapy
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial
Yosuke Koshikawa, Yoshiteru Takekita, Masaki Kato, Shiho Sakai, Ai Onohara, Naotaka Sunada, Keiichiro Nishida, Masafumi Yoshimura, Chiara Fabbri, Alessandro Serretti et al. · 2016 · Neuropsychobiology
Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study
David Misdrahi, A. Tessier, Mathilde M. Husky, Anne-Catherine Lange, Bernard Vrijens, Pierre‐Michel Llorca, François Bayle · 2017 · Schizophrenia Research
Impact of symptom resolution on medication adherence in first episode psychosis
Katherine A. Steger, Clifford Cassidy, Mark Rabinovitch, Ridha Joober, ASHOK K. MALLA · 2012 · Psychiatry Research
Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 1: tratamento agudo
Peter Falkai, Thomas Wobrock, Jeffrey Alan Lieberman, Birte Yding Glenthoj, Wagner F. Gattaz, Hans‐Jürgen Möller · 2006 · Archives of Clinical Psychiatry (São Paulo)
Motivational Interviewing in Psychotic Disorders
Emile Barkhof, Lieuwe de Haan, Carin J. Meijer, Annemarie Fouwels, Ireneus P.M. Keet, Kai P. Hulstijn, Gerard M. Schippers, DON H. LINSZEN · 2006 · Current Psychiatry Reviews
Effect of initial ziprasidone dose on length of therapy in schizophrenia
Amie T. Joyce, David James Harrison, Antony D Loebel, Chureen T. Carter, Daniel A. Ollendorf · 2006 · Schizophrenia Research
Schizophrenia and medication adherence: Associated factors.
Karabulut, Buse, Uslu, Esra · 2024 · Archives of Psychiatric Nursing
Acceptance and commitment therapy for inpatients with psychosis (the REACH study): protocol for treatment development and pilot testing
Gaudiano, Brandon, Davis, Carter, Epstein-Lubow, Gary, Johnson, Jennifer, Mueser, Kim, Miller, Ivan · 2017 · Healthcare
The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients
Mitsi H. Lizer · 2013 · Mental Health Clinician
Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia
Alejandra Caqueo‐Urízar, Alfonso Urzúa M, Patricio Mena‐Chamorro, Guillaume B. Fond, Laurent Boyer · 2020 · Patient Preference and Adherence
Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
Cecilio Álamo · 2022 · Advances in Therapy
Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia
Delbert G. Robinson, Mark Suett, Amanda Wilhelm, Nayla Chaijale, Kelli R. Franzenburg, Sanjay K Gandhi, Blaine Cloud, Marko A. Mychaskiw · 2023 · Advances in Therapy
Concomitant Psychotropic Medication Use During Treatment of Schizophrenia Patients: Longitudinal Results from the CATIE Study
Miranda Chakos, Javendra Patel, Robert Alan Rosenheck, Ira D. Glick, Mark B. Hamner, Del D. Miller, Andre M. Tapp, Alexander L. Miller · 2011 · Clinical Schizophrenia & Related Psychoses
Assertive Community Treatment in Veterans Affairs Settings: Impact on Adherence to Antipsychotic Medication
Marcia M. Valenstein, John F. McCarthy, Dara A. Ganoczy, Nicholas W. Bowersox, Lisa B. Dixon, Richard Miller, Stephanie Visnic, Eric P. Slade · 2013 · Psychiatric Services
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice
Nghiem B. Ha, Huy Ngoc Trinh, Lisa C. Rosenblatt, Dat Nghiem, Mindie H. Nguyen · 2015 · Journal of Clinical Gastroenterology